Analysed INTERCURE LTD (INCR:NASDAQ) News Sources
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
03-11-2025
yahoo.com
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
19-02-2026
yahoo.com
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
19-02-2026
yahoo.com
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
30-04-2026
yahoo.com
InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition
15-06-2026
yahoo.com
InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds
22-06-2026
yahoo.com
InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect Damages
24-08-2026
yahoo.com
InterCure (INCR) Finalized a $77M Settlement, but How Much New Cash Will it Receive?
27-08-2026
yahoo.com
What is the current price of INTERCURE LTD (INCR:NASDAQ)?
The current price of INTERCURE LTD (INCR:NASDAQ) is $5.31.
INTERCURE LTD (INCR:NASDAQ) absolute price change since previous trading day?
The absolute price change of INTERCURE LTD (INCR:NASDAQ) since the previous trading day is $0.18.
INTERCURE LTD (INCR:NASDAQ) percentage price change since previous trading day?
The percentage price change of INTERCURE LTD (INCR:NASDAQ) since the previous trading day is 3.5088%.
What is the most recent average sentiment score for INTERCURE LTD (INCR:NASDAQ)?
The most recent average sentiment score for INTERCURE LTD (INCR:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for INTERCURE LTD (INCR:NASDAQ)?
The most recent sentiment for INTERCURE LTD (INCR:NASDAQ) is .
SEC-8K** Filing Available For INTERCURE LTD (INCR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.